-
CPI-203
- names:
CPI-203
- CAS号:
1446144-04-2
MDL Number: - MF(分子式): C19H18ClN5OS MW(分子量): 399.9
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM001231-5mg | 5mg | 99.4% | ¥ 1620.00 | ¥ 1620.00 | 2-3天 | ¥ 0.00 | ||
| YZM001231-2mg | 2mg | 99.4% | ¥ 975.00 | ¥ 975.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1446144-04-2 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C19H18ClN5OS |
| 分子量 Molecular Weight | 399.9 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 47 mg/mL(117.53 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
CPI-203(CAS:1446144-04-2)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | CPI-203 是一种有效的,选择性的,细胞通透的BET bromodomain抑制剂,抑制BRD4,IC50值约为 37 nM |
| Introduction | CPI03 is a novel potent, selective and cell permeable inhibitor of BET bromodomain, with anIC50value of appr 37 nM (BRD4 αcreen assay). |
| Application1 | |
| Application2 | |
| Application3 |
CPI-203 是一种有效的,选择性的,细胞通透的BET bromodomain抑制剂,抑制BRD4,IC50值约为 37 nM。CPI-203 is a novel potent, selective and cell permeable inhibitor ofBET bromodomain, with anIC50value of appr 37 nM (BRD4 α-screen assay).
【1】.Devaiah BN, et al. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A. 2012 May 1;109(18):6927-32.
【2】.Moros A, et al. Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma. Leukemia. 2014 Oct;28(10):2049-59
【2】.Moros A, et al. Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma. Leukemia. 2014 Oct;28(10):2049-59
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


